Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.
Litton E, Baker S, Erber W, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, De Keulenaer B, McMorrow J, Olynyk JK, Richards T, Towler S, Trengove R, Webb S; IRONMAN Study investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.
Litton E, et al.
J Intensive Care. 2018 Sep 10;6:60. doi: 10.1186/s40560-018-0328-2. eCollection 2018.
J Intensive Care. 2018.
PMID: 30214812
Free PMC article.